| 1 |
Scarpignato C, Hongo M, Wu J C Y, et al. Pharmacologic treatment of GERD: Where we are now, and where are we going?[J]. Ann N Y Acad Sci, 2020, 1482(1):193-212.
|
| 2 |
Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease[J]. Gut Liver,2018, 12 (1): 7-16.
|
| 3 |
Pauwels A, Boecxstaens V, Andrews C N, et al. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery)[J]. Gut,2019, 68(11): 1928-1941.
|
| 4 |
Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus[J]. Gut, 2018, 67(7): 1351-1362.
|
| 5 |
汪忠镐, 吴继敏, 胡志伟, 等. 中国胃食管反流病多学科诊疗共识[J/OL]. 中国医学前沿杂志(电子版), 2019, 11(09): 30-56.
|
| 6 |
Macfarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist's perspective[J]. Integr Pharm Res Pract, 2018, 7: 41-52.
|
| 7 |
皮尔地瓦斯·麦麦提玉素甫, 艾克拜尔·艾力, 买买提·依斯热依力, 等. 腹腔镜胃底折叠术联合胃袖状切除术治疗肥胖合并胃食管反流病临床研究[J]. 中国实用外科杂志, 2020, 40(4): 437-440, 443.
|
| 8 |
陈利嫒, 王佳, 侯奕同. 胃食管反流病治疗的研究进展[J].国际消化病杂志,2020, 40(4): 215-218.
|
| 9 |
陈旻湖, 侯晓华, 肖英莲, 等. 2014年中国胃食管反流病专家共识意见[J]. 胃肠病学, 2015, 20(3):155-168.
|
| 10 |
Roark R, Sydor M, Chatila AT, et al. Management of gastroesophageal reflux disease[J]. Dis Mon, 2020, 66 (1): 100849.
|
| 11 |
Jiang M, Chen P, Gao Q. Systematic review and net-work meta-analysis of upper gastrointestinal hemorrhage interventions[J]. Cell Physiol Biochem,2016, 39(6): 2477-2491.
|
| 12 |
Helgadottir H, Bjornsson ES. Problems associated with deprescribing of proton pump inhibitors[J]. Int J Mol Sci, 2019, 20(21): 5469.
|
| 13 |
Poddar U. Gastroesophageal reflux disease (GERD) in children[J]. Paediatr Int Child Health, 2019, 39(1): 7-12.
|
| 14 |
何海涛, 丁西平, 王金平, 等. 长期使用质子泵抑制剂对老年胃食管反流病患者肠道菌群的影响[J].山东医药,2018,58(18):47-50.
|
| 15 |
Eusebi LH, Rabitti S, Artesiani ML, et al. Proton pump inhibitors: risks of long-term use[J]. J Gastroenterol Hepatol, 2017, 32(7): 1295-1302.
|
| 16 |
Brar T S, Draganov P V, Yang D. Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife?[J]. Dig Dis Sci, 2017, 62 (1): 16-25.
|
| 17 |
Park S, Park S, Park J M, et al. Anti-reflux surgery versus proton pump inhibitors for severe gastroesophageal reflux disease: a cost-effectiveness study in Korea[J]. J Neurogastroenterol Motil, 2020, 26(2): 215-223.
|
| 18 |
Sugano K. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date[J]. Therap Adv Gastroenterol, 2018, 11: 1756283X17745776.
|
| 19 |
Yang X, Li Y, Sun Y, et al. Vonoprazan: a novel and potent alternative in the treatment of acid-related diseases[J]. Dig Dis Sci, 2018, 63(2): 302-311.
|
| 20 |
Dent J, Kahrilas P J, Hatlebakk J, et al. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease[J]. Am J Gastroenterol, 2008, 103(1): 20-26.
|
| 21 |
Miwa H, Igarashi A, Teng L, et al. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease[J]. J Gastroenterol, 2019, 54(8): 718-729.
|
| 22 |
Young A, Kumar MA, Thota PN. GERD: A practical approach[J].Cleve Clin J Med, 2020, 87(4): 223-230.
|
| 23 |
Rouphael C, Padival R, Sanaka MR, et al. Endoscopic treatments of GERD[J]. Curr Treat Options Gastroenterol, 2018, 16(1): 58-71.
|
| 24 |
Mayor MA, Fernando HC. Endoluminal approaches to gastroesophageal reflux disease[J]. Thorac Surg Clin, 2018, 28(4): 527-532.
|
| 25 |
Kim H J, Kwon C I, Kessler W R, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE endoscopic stapling device[J]. Surg Endosc, 2016, 30(8): 3402-3408.
|
| 26 |
Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229.
|
| 27 |
Schwameis K, Oh D, Green K M, et al. Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn[J]. Dis Esophagus, 2020, 32(4): doz099.
|
| 28 |
李慧灵, 阿不来提·艾则孜, 张成, 等. 胃食管反流病诊治进展[J/OL].中华胃食管反流病电子杂志,2015,2(03):175-177.
|
| 29 |
Richter J E, Kumar A, Lipka S, et al. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis[J]. Gastroenterology, 2018, 154(5): 1298-1308 e7.
|
| 30 |
阿卜杜喀迪尔·阿卜杜热合曼, 克力木·阿不都热依木. 腹腔镜抗反流手术相关并发症及其处理[J/OL].中华胃食管反流病电子杂志,2019, 6(3): 166-170.
|
| 31 |
艾克拜尔·艾力, 麦麦提艾力·麦麦提明, 克力木·阿不都热依木. 3D腹腔镜与2D腹腔镜在食管裂孔疝修补术联合Nissen胃底折叠术中应用的临床疗效对比分析[J/OL].中华胃食管反流病电子杂志, 2017, 4(2): 66-68.
|
| 32 |
安丽娟, 俞永江. 胃食管反流病的治疗进展[J/OL].中华胃食管反流病电子杂志,2019, 6(2): 87-91.
|
| 33 |
Spechler S J, Hunter J G, Jones K M, et al. Randomized trial of medical versus surgical treatment for refractory heartburn[J]. N Engl J Med, 2019, 381(16): 1513-1523.
|
| 34 |
Park C H. Cost-effective management of severe gastroesophageal reflux disease: toward an improved understanding of anti-reflux surgery[J]. J Neurogastroenterol Motil, 2020, 26(2): 169-170.
|
| 35 |
买买提·依斯热依力, 艾克拜尔·艾力, 吾布力卡斯木·吾拉木, 等. 饮食诱导小鼠肥胖模型中胃食管黏膜的变化研究[J/OL].中华胃食管反流病电子杂志,2018,5(1):10-14.
|